CTI BioPharma
CTIC
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)
Categories
CTI BioPharma (CTIC) Fails to deliver data
Key failure to deliver metrics for CTI BioPharma :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $44.94 M
Failures to deliver for CTI BioPharma (CTIC) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for CTI BioPharma (CTIC) - since 2017
Volume in USD (price x number of shares), data since 2017CTI BioPharma (CTIC) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $48.33 M | -1.16% |
| 2022 | $48.9 M | 295.24% |
| 2021 | $12.37 M | 127.59% |
| 2020 | $5.43 M | 359.78% |
| 2019 | $1.18 M | -84.36% |
| 2018 | $7.56 M | -2.48% |
| 2017 | $7.75 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | $30.53 M | $95.22 M | 🇨🇭 Switzerland |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Baxter BAX | $8.04 M | $0.18 B | 🇺🇸 USA |
 Incyte INCY | $81.65 M | $0.10 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | 🇮🇱 Israel |